GPP
ETNB

Great Point Partners’s 89bio ETNB Stock Holding History

Great Point Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-250,000
Closed -$3.81M – 44
2023
Q1 		$3.81M Buy
+250,000
New +$3.26M 0.75% 34
2022
Q4 		– Sell
-955,000
Closed -$5.53M – 45
2022
Q3 		$5.53M Sell
955,000
-445,000
-32% -$1.96M 1.33% 25
2022
Q2 		$4.51M Buy
+1,400,000
New +$4.23M 1.08% 31

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Great Point Partners's ETNB Position: Q2 2023 in Review

Great Point Partners sold out of 89bio (ETNB) in Q2 2023, closing a stake of 250,000 shares — an estimated $3.81M sold.

Great Point Partners first reported a position in ETNB in Q2 2022 and held it in 3 quarters. The position peaked at $5.53M in Q3 2022. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

  • Great Point Partners reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
  • Great Point Partners sold 250,000 89bio shares in Q2 2023, an estimated $3.81M.
  • Great Point Partners first reported a position in 89bio in Q2 2022 and held it in 3 quarters.
  • Great Point Partners's 89bio position peaked at $5.53M in Q3 2022.
  • 157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Great Point Partners's 13F filing for Q2 2023, filed 14 Aug 2023.